News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Er-kim Pharmaceuticals Actively Supports the Global Campaign to Prevent Antimicrobial Resistance (Amr)
Friday, November 24, 2023ErKim Pharmaceuticals an international pharmaceutical company specializing in the commercialization of novel therapies has joined the effort to combat antimicrobial resistance by participating in World AMR
Boehringer Ingelheim Expands Its Immuno-oncology Portfolio Through the Acquisition of T3 Pharma, a Specialist in Bacterial Cancer Therapy
Thursday, November 23, 2023Boehringer Ingelheim has recently completed the acquisition of T Pharmaceuticals AG a Swiss biotech company for an amount of up to million CHF T Pharma specializes in a unique therapy platform
Myricx Bio and Wuxi Biologics Establish Exclusive Agreement for Antibody Licensing
Wednesday, November 22, 2023Myricx Bio a UKbased biotech firm focused on discovering and developing a new class of antibodydrug conjugate payloads centered on NMyristoyltransferase inhibition has announced a licensing agreement
Genentech and NVIDIA Establish Strategic Collaboration for AI Research to Enhance Drug Discovery and Development
Wednesday, November 22, 2023Genentech a member of the Roche Group has recently unveiled a strategic research partnership with NVIDIA a global leader in accelerated computing and artificial intelligence The collaboration is designed
Metabolon and Trajan Collaborate on Advancing Microsampling Solutions for Metabolomics Research
Tuesday, November 21, 2023Metabolon Inc a leading global provider of metabolomics solutions for life science research and Trajan Scientific and Medical the innovator behind Neoteryx Mitra biological sample collection devices
Astrazeneca Achieves US Marketing Authorization for Cancer Medication Truqap (Capivasertib) in Third Milestone of Astex Drug Discovery Collaboration
Monday, November 20, 2023Astex Pharmaceuticals has recently revealed its anticipation of receiving a milestone payment from AstraZeneca subsequent to the US Food and Drug Administrations approval of TruqapTM plus Faslodex
BeiGene Secures Approval from the European Commission for BRUKINSA® (zanubrutinib) in the Treatment of Relapsed or Refractory Follicular Lymphoma
Saturday, November 18, 2023BeiGene Ltd has announced that the European Commission has granted marketing authorization for BRUKINSA in combination with obinutuzumab for the treatment of adult patients
Argenx Secures European Commission Nod for Subcutaneous Vyvgart® (Efgartigimod Alfa) in Treating Generalized Myasthenia Gravis
Friday, November 17, 2023Argenx SE a global immunology company listed on Euronext and Nasdaq under the ticker ARGX has recently obtained approval from the European Commission for its SC injectable VYVGART
PostEra and Amgen Collaborate on Research Using Artificial Intelligence for Small Molecule Therapeutics Discovery
Friday, November 17, 2023PostEra a biotechnology company specializing in artificial intelligence for preclinical drug discovery has recently announced a comprehensive collaboration with Amgen
Astellas Pharma's Acquisition of Propella Therapeutics
Thursday, November 16, 2023Astellas Pharma Inc and Propella Therapeutics Inc have jointly declared a merger agreement wherein Astellas will acquire Propella through its US subsidiary Propella a privately held biopharmaceutical firm specializes in developing new oncology drugs...
